Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.

At current levels, we believe GILD scores above BMY, buoyed by solid fundamentals, potential approval of lenacapavir for HIV ...

Ten UCSF graduate students presented their research in accessible, 3-minute talks at the 2025 Grad Slam event. This year’s ...

HIV, or Human Immunodeficiency Virus, is a type of virus that weakens the immune system, making one susceptible to a variety of infections. Although there is no cure for HIV, with the right treatment, ...

Early on, human immunodeficiency virus (HIV) typically causes flu ... attacks cells in your immune system known as CD4 cells. If untreated, HIV may progress to acquired immunodeficiency syndrome ...

Health Secretary Robert F. Kennedy Jr.’s purge of tens of thousands of federal workers has halted efforts to collect data on everything from cancer rates in firefighters to mother-to-baby transmission ...

Mar. 19, 2025 — New study demonstrates how high-affinity B cells 'bank' their ... Until now, how the virus manages to ... New Therapy May Effectively Control HIV in Uganda Feb. 19, 2025 ...

The study found 20% of women who took a drug intervention that included antibodies remained virally suppressed without ...

Lenacapavir works by stopping HIV from making more copies of itself and so getting into someone's immune cells. What made ...

Contamination is one of the main roadblocks to successful cell culture. This article explores the different types of ...